Prana’s website has not been updated for over 3 years.
The following opening paragraph is from the “About Us” tab on their website;
Prana Biotechnology is developing first-in-class therapies to treat neurodegenerative disease.
The Company's lead drug candidate – PBT2 – is being developed for the treatment of Alzheimer’s and Huntington's diseases. The Company is targeting lodgement of a New Drug Application for Huntington's disease in 2016/2017 pending positive trial results.
Pretty poor effort but I guess it is just following the standards it set many years ago.
Now eagerly awaiting information on the PBT434 clinical trial to commence but if Prana is true to form this will also be delayed well into 2018 with no updates being provided as usual.
I still have embedded in my mind the words of Kempler 2 years ago on how Prana was all about creating shareholder value going forward. Well that fell on deaf ears.
Prana website
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $7.879K | 2.590M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 79758033 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1157860 | 1 |
View Market Depth
| Last trade - 15.57pm 17/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |